Jefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy
Investing.com -- Jefferies upgraded Bristol-Myers Squibb Company (NYSE: BMY ) to "buy" from "hold" and raised its price target by $7 to $70, amid an improved confidence in the company’...
Trump signals potential reconsideration of TikTok ban
In a recent turn of events, President-elect Donald Trump has indicated a possible reassessment of the impending prohibition of TikTok Inc., a stance that contrasts with his previous position duri...
Pharmacy benefit manager stocks dip following Trump's vow to cut drug costs
In the wake of President-elect Donald Trump's recent declaration to eliminate the "middle man" in an effort to reduce prescription drug costs, shares of companies that own pharmacy benefit manage...
